384 related articles for article (PubMed ID: 28883264)
1. [Treatment algorithms for multiple myeloma in Japan].
Ozaki S
Rinsho Ketsueki; 2017; 58(8):1014-1023. PubMed ID: 28883264
[TBL] [Abstract][Full Text] [Related]
2. [Current treatment of refractory and relapsed multiple myeloma].
Sasaki M
Rinsho Ketsueki; 2016; 57(10):2084-2095. PubMed ID: 27795518
[TBL] [Abstract][Full Text] [Related]
3. The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy.
Voorhees PM; Usmani SZ
Clin Adv Hematol Oncol; 2016 Sep; 14(9):719-28. PubMed ID: 27673290
[TBL] [Abstract][Full Text] [Related]
4. Emerging therapies in multiple myeloma.
El-Amm J; Tabbara IA
Am J Clin Oncol; 2015 Jun; 38(3):315-21. PubMed ID: 23934133
[TBL] [Abstract][Full Text] [Related]
5. The future of therapy for relapsed/refractory multiple myeloma: emerging agents and novel treatment strategies.
Moreau P
Semin Hematol; 2012 Jul; 49 Suppl 1():S33-46. PubMed ID: 22727391
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma treatment at relapse after autologous stem cell transplantation: A practical analysis.
Malard F; Harousseau JL; Mohty M
Cancer Treat Rev; 2017 Jan; 52():41-47. PubMed ID: 27888768
[TBL] [Abstract][Full Text] [Related]
7. [Management of multiple myeloma in the relapsed/refractory patient].
Tabayashi T
Rinsho Ketsueki; 2019; 60(9):1257-1264. PubMed ID: 31597851
[TBL] [Abstract][Full Text] [Related]
8. How have evolutions in strategies for the treatment of relapsed/refractory multiple myeloma translated into improved outcomes for patients?
Sonneveld P; De Wit E; Moreau P
Crit Rev Oncol Hematol; 2017 Apr; 112():153-170. PubMed ID: 28325256
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma: from front-line to relapsed therapies.
Moreau P; Touzeau C
Am Soc Clin Oncol Educ Book; 2015; ():e504-11. PubMed ID: 25993216
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy of multiple myeloma.
Kyle RA
Hematology; 2012 Apr; 17 Suppl 1():S125-8. PubMed ID: 22507799
[TBL] [Abstract][Full Text] [Related]
11. New Agents in Multiple Myeloma: An Examination of Safety Profiles.
Bringhen S; De Wit E; Dimopoulos MA
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):391-407.e5. PubMed ID: 28601492
[TBL] [Abstract][Full Text] [Related]
12. New developments in post-transplant maintenance treatment of multiple myeloma.
Liu H; McCarthy P
Semin Oncol; 2013 Oct; 40(5):602-9. PubMed ID: 24135405
[TBL] [Abstract][Full Text] [Related]
13. Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma.
Highsmith KN; Chen SE; Horowitz S
Pharmacotherapy; 2014 Sep; 34(9):927-40. PubMed ID: 25044413
[TBL] [Abstract][Full Text] [Related]
14. Stem Cell Transplantation in Multiple Myeloma.
Offidani M; Gentili S; Gay F; Aghemo E; Maracci L; Corvatta L; Palumbo A
Curr Cancer Drug Targets; 2017; 17(9):769-781. PubMed ID: 27659429
[TBL] [Abstract][Full Text] [Related]
15. The role of pre-transplant induction regimens and autologous stem cell transplantation in the era of novel targeted agents.
Gay F; Cavallo F; Palumbo A
Drugs; 2015 Mar; 75(4):367-75. PubMed ID: 25764394
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma.
Harousseau JL; Shaughnessy J; Richardson P
Hematology Am Soc Hematol Educ Program; 2004; ():237-56. PubMed ID: 15561686
[TBL] [Abstract][Full Text] [Related]
17. New developments in the management and treatment of newly diagnosed and relapsed/refractory multiple myeloma patients.
van de Donk NW; Lokhorst HM
Expert Opin Pharmacother; 2013 Aug; 14(12):1569-73. PubMed ID: 23721099
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of consolidation and maintenance therapy for transplant-eligible multiple myeloma patients.
McCarthy PL; Einsele H; Attal M; Giralt S
Expert Rev Hematol; 2014 Feb; 7(1):55-66. PubMed ID: 24471885
[TBL] [Abstract][Full Text] [Related]
19. [Treatment strategy for relapsed or refractory myeloma according to the new Guidelines].
Ozaki S
Rinsho Ketsueki; 2018; 59(10):2178-2188. PubMed ID: 30305524
[TBL] [Abstract][Full Text] [Related]
20. Current strategies for treatment of relapsed/refractory multiple myeloma.
Laubach JP; Voorhees PM; Hassoun H; Jakubowiak A; Lonial S; Richardson PG
Expert Rev Hematol; 2014 Feb; 7(1):97-111. PubMed ID: 24471924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
